Trial · NCT04843579
Adverse events33
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 33
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anemia | Blood and lymphatic system disorders | Selinexor, Clarithromycin, Pomalidomide and Dexamethasone (ClaSPd) | 1 | 4 | |
| other | Anorexia | Metabolism and nutrition disorders | Selinexor, Clarithromycin, Pomalidomide and Dexamethasone (ClaSPd) | 1 | 4 | |
| other | Blurred vision | Eye disorders | Selinexor, Clarithromycin, Pomalidomide and Dexamethasone (ClaSPd) | 1 | 4 | |
| other | Concentration Impairment | Nervous system disorders | Selinexor, Clarithromycin, Pomalidomide and Dexamethasone (ClaSPd) | 1 | 4 | |
| other | Confusion | Psychiatric disorders | Selinexor, Clarithromycin, Pomalidomide and Dexamethasone (ClaSPd) | 1 | 4 | |
| other | Constipation | Gastrointestinal disorders | Selinexor, Clarithromycin, Pomalidomide and Dexamethasone (ClaSPd) | 1 | 4 | |
| other | COVID-19 Infection | Infections and infestations | Selinexor, Clarithromycin, Pomalidomide and Dexamethasone (ClaSPd) | 1 | 4 | |
| other | Dizziness | Nervous system disorders | Selinexor, Clarithromycin, Pomalidomide and Dexamethasone (ClaSPd) | 2 | 4 | |
| other | Dysgeusia | Nervous system disorders | Selinexor, Clarithromycin, Pomalidomide and Dexamethasone (ClaSPd) | 1 | 4 | |
| other | Dyspnea | Respiratory, thoracic and mediastinal disorders | Selinexor, Clarithromycin, Pomalidomide and Dexamethasone (ClaSPd) | 1 | 4 | |
| other | Fall | Injury, poisoning and procedural complications | Selinexor, Clarithromycin, Pomalidomide and Dexamethasone (ClaSPd) | 1 | 4 | |
| other | Fatigue | General disorders | Selinexor, Clarithromycin, Pomalidomide and Dexamethasone (ClaSPd) | 3 | 4 | |
| other | Flatulence | Gastrointestinal disorders | Selinexor, Clarithromycin, Pomalidomide and Dexamethasone (ClaSPd) | 1 | 4 | |
| other | Bloating | Gastrointestinal disorders | Selinexor, Clarithromycin, Pomalidomide and Dexamethasone (ClaSPd) | 1 | 4 | |
| other | Gait Disturbance | General disorders | Selinexor, Clarithromycin, Pomalidomide and Dexamethasone (ClaSPd) | 1 | 4 | |
| other | Generalized Muscle Weakness | Musculoskeletal and connective tissue disorders | Selinexor, Clarithromycin, Pomalidomide and Dexamethasone (ClaSPd) | 1 | 4 | |
| other | Headache | Nervous system disorders | Selinexor, Clarithromycin, Pomalidomide and Dexamethasone (ClaSPd) | 1 | 4 | |
| other | Hyperglycemia | Metabolism and nutrition disorders | Selinexor, Clarithromycin, Pomalidomide and Dexamethasone (ClaSPd) | 1 | 4 | |
| other | Insomnia | Psychiatric disorders | Selinexor, Clarithromycin, Pomalidomide and Dexamethasone (ClaSPd) | 1 | 4 | |
| other | Irritability | Psychiatric disorders | Selinexor, Clarithromycin, Pomalidomide and Dexamethasone (ClaSPd) | 1 | 4 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04843579/events